⚠ Evidence warning: Clinical trials or other evidence do not support the claim that ringworm bush leaf treats ringworm, tinea imbricata and pityriasis versicolor. This page keeps it as a report of what people, websites or other media say.

Ringworm Bush — Benefits Deep Dive

Staphylococcus bacteria, a skin infection germ
Staphylococcus bacteria, a skin infection germ

The most surprising fact this set turned up is not about the antifungal claim ringworm bush is named for. It is that the plant's single best piece of clinical evidence — an actual three-arm randomised controlled trial with a real placebo group — is for the laxative effect its own main page cautions against. (The only other placebo-controlled human trials found are two small Philippine trials of a ringworm bush lotion for scabies, which a 2025 review rated very low certainty; see the ledger.) That single fact reorganises everything else here. Four pages follow the evidence rather than the plant's marketing, folk name or the brief that first proposed them: they broaden "wound healing" into the much larger antibacterial literature it actually has; they name a specific, checkable reason the antioxidant and anti-inflammatory claims are the weakest tier despite generating the largest raw search count; and they trace one compound family, the anthraquinones, through a benefit (plausible topical antimicrobial action), a proven effect (the laxative randomized controlled trial, RCT), and a hazard (potassium loss and dependence on chronic internal use) that are all, mechanistically, the same story.

Deep-Dive Articles

🍄

Antifungal Activity and Ringworm Treatment

The plant's namesake claim, taken further than the main page can go: the real mechanism (including a 2024 computational docking result against the same enzyme azole drugs hit), the strong in-vitro record with real minimum inhibitory concentration (MIC) arithmetic against pharmaceutical standards, and three separate pieces of human evidence — a prospective Philippine tinea imbricata study, a Nigerian schoolchildren susceptibility survey, and an old, unverifiable 1994 report — each with a distinct and different limitation, none of them a controlled trial.

Read the deep dive →
🚽

Laxative Effect and Anthraquinone Chemistry

The plant's best-evidenced claim by far — a real 1990 Thai randomized controlled trial against placebo and an active comparator — and the potassium-loss and dependence hazards that anthraquinone laxatives carry with chronic use. The mechanism, the quantified anthraquinone chemistry, a direct real-world parallel (rhein's career as the drug diacerein), a checked-and-rejected coumarin caution, and a genotoxicity signal reported at exactly the size it was found.

Read the deep dive →
🦠

Antibacterial Activity and Skin Infections

Why "wound healing" undersold this plant's second-largest evidence base. A cellulitis-specific Staphylococcus aureus study with real MIC numbers, a methicillin-resistant S. aureus finding traced to a specific compound and structural requirement, modern anti-biofilm and anti-quorum-sensing mechanisms, and the closest thing to actual wound-healing evidence this plant has — human keratinocyte migration data, reported with exactly the caveat that distinguishes it from a clinical trial.

Read the deep dive →
🔬

Antioxidant, Anti-Inflammatory and Other Preclinical Claims

The largest raw literature and the weakest evidence tier, explained rather than asserted. Includes the doctrine's tyrosinase trap caught in the wild — two real studies that support cosmetic skin-lightening, not the repigmentation a reader recovering from tinea versicolor might hope for — plus a part-substitution flag on the antidiabetic claim (flower, not leaf) and the acarbose ceiling that bounds what its mechanism could plausibly achieve.

Read the deep dive →

Back to Table of Contents

Table of Contents

  1. Deep-Dive Articles
  2. Evidence Ledger
  3. One Mechanism, Three Faces
  4. A Note on How This Set Diverged From Its Brief
  5. Key Research: Antifungal Activity
  6. Key Research: Laxative Effect and Chemistry
  7. Key Research: Antibacterial Activity
  8. Key Research: Antioxidant, Anti-Inflammatory and Other Claims
  9. External Resources
  10. Connections
  11. Featured Videos

Evidence Ledger

Claims ranked by the strength of what actually supports them, not by how famous they are or how many search results they generate.

Best supported — randomised controlled trials

Real human evidence, three different kinds of incomplete

Laboratory only, real and repeated

Single-study or preliminary

Checked and qualified or refused

Mechanistically necessary harms, from the same chemistry that produces the benefits above

One Mechanism, Three Faces

Read top to bottom, the ledger above traces a single chemical thread. The anthraquinones — chiefly aloe-emodin, rhein, emodin and chrysophanol — are lipophilic, membrane-active compounds. Applied to skin, that property plausibly disrupts a fungal or bacterial cell membrane (the antifungal and antibacterial pages). Swallowed, the same compounds — travelling as sugar-bound glycosides until gut bacteria free them in the colon — produce a genuine, randomized controlled trial-proven laxative effect, and with chronic use, the electrolyte and dependence risks that are this plant's most serious documented hazard (the laxative page). One compound family; a benefit and a hazard that are, mechanistically, the same fact stated in two different tissues. Rhein's own separate career as the active metabolite of the osteoarthritis drug diacerein — whose most common side effect is diarrhoea — is a real-world demonstration of exactly this duality, entirely independent of this plant.

A Note on How This Set Diverged From Its Brief

The brief that proposed this set suggested "wound-healing and skin-infection use" as a third topic alongside antifungal activity, laxative chemistry and antioxidant/anti-inflammatory claims. A species-locked search for wound-healing evidence specifically returned a small handful of records — far too thin to support a dedicated page at the depth the rest of this set was written to. A search for antibacterial activity broadly, which subsumes the traditional wound and insect-bite use without being limited to it, returned nearly ten times as many records, including the plant's most clinically pointed finding (activity against methicillin-resistant Staphylococcus aureus, traced to a specific compound and a defined structural requirement) and its closest approach to real wound-healing evidence (human keratinocyte migration data). The third page was built around that broader, better-evidenced topic instead, and is titled accordingly. The brief was treated as a starting hypothesis and checked against the literature before the pages were written.

Key Research: Antifungal Activity

  1. Eusebio-Alpapara KMV, Dofitas BL, Balita-Crisostomo CLA, et al. Senna (Cassia) alata (Linn.) Roxb. leaf decoction as a treatment for tinea imbricata in an indigenous tribe in Southern Philippines. Mycoses, 2020;63(11):1226-1234 — the best human study. PubMed PMID: 32779266
  2. Eja ME, Arikpo GE, Enyi-Idoh KH, Etim SE, Etta HE. Efficacy of local herbal therapy in the management of dermatophytosis among primary school children in Cross River State, South-south Nigeria. African Journal of Medicine and Medical Sciences, 2009;38(2):135-41 — the Nigerian schoolchildren dermatophytosis survey. PubMed PMID: 20175416
  3. Saptarini NM, Mustarichie R, Hasanuddin S, Corpuz MJT. Cassia alata L.: A Study of Antifungal Activity against Malassezia furfur, Identification of Major Compounds, and Molecular Docking to Lanosterol 14-Alpha Demethylase. Pharmaceuticals (Basel), 2024;17(3) — lanosterol demethylase docking. PubMed PMID: 38543166
  4. Crockett CO, Guede-Guina F, Pugh D, et al. Cassia alata and the preclinical search for therapeutic agents for the treatment of opportunistic infections in AIDS patients. Cell and Molecular Biology, 1992;38(5):505-11 — comparative MIC data against chloramphenicol and amphotericin B. PubMed PMID: 1468110
  5. Damodaran S, Venkataraman S. A study on the therapeutic efficacy of Cassia alata, Linn. leaf extract against Pityriasis versicolor. Journal of Ethnopharmacology, 1994;42(1):19-23 — the 1994 pityriasis versicolor report. PubMed PMID: 8046939
  6. Comparative trial literature for topical terbinafine and clotrimazole — the pharmaceutical benchmark. — Search PubMed

Key Research: Laxative Effect and Chemistry

  1. Thamlikitkul V, Bunyapraphatsara N, Dechatiwongse T, et al. Randomized controlled trial of Cassia alata Linn. for constipation. Journal of the Medical Association of Thailand, 1990;73(4):217-22 — the flagship trial of this entire set. PubMed PMID: 2203870
  2. Panichayupakaranant P, Sakunpak A, Sakunphueak A. Quantitative HPLC determination and extraction of anthraquinones in Senna alata leaves. Journal of Chromatographic Science, 2009;47(3):197-200 — validated high-performance liquid chromatography (HPLC) anthraquinone quantification. PubMed PMID: 19298705
  3. Hennebelle T, Weniger B, Joseph H, Sahpaz S, Bailleul F. Senna alata. Fitoterapia, 2009;80(7):385-93 — comprehensive chemistry and pharmacology review. PubMed PMID: 19446609
  4. Anthraquinone laxatives and hypokalaemia.
  5. Melanosis coli and chronic anthraquinone use.

Key Research: Antibacterial Activity

  1. Hazni H, Ahmad N, Hitotsuyanagi Y, Takeya K, Choo CY. Phytochemical constituents from Cassia alata with inhibition against methicillin-resistant Staphylococcus aureus (MRSA). Planta Medica, 2008;74(15):1802-5 — MRSA-active compounds and structural requirement. PubMed PMID: 18991205
  2. Toh SC, Lihan S, Bunya SR, Leong SS. In vitro antimicrobial efficacy of Cassia alata (Linn.) leaves, stem, and root extracts against cellulitis causative agent Staphylococcus aureus. BMC Complementary Medicine and Therapies, 2023;23(1):85 — cellulitis-associated S. aureus. PubMed PMID: 36934252
  3. Rekha PD, Vasavi HS, Vipin C, Saptami K, Arun AB. A medicinal herb Cassia alata attenuates quorum sensing in Chromobacterium violaceum and Pseudomonas aeruginosa. Letters in Applied Microbiology, 2017;64(3):231-238 — quorum-sensing inhibition. PubMed PMID: 28035685
  4. Lee SK, Keng JW, Yon JA, et al. Phytochemical Analysis and Biological Activities of Flavonoids and Anthraquinones from Cassia alata (Linnaeus) Roxburgh and Their Implications for Atopic Dermatitis Management. Plants (Basel), 2025;14(3):362 — human keratinocyte migration data. PubMed PMID: 39942922
  5. Saito ST, Trentin Dda S, Macedo AJ, et al. Bioguided Fractionation Shows Cassia alata Extract to Inhibit Staphylococcus epidermidis and Pseudomonas aeruginosa Growth and Biofilm Formation. Evidence-Based Complementary and Alternative Medicine, 2012;2012:867103 — anti-biofilm activity and compound identification. PubMed PMID: 22548121

Key Research: Antioxidant, Anti-Inflammatory and Other Claims

  1. Chatatikun M, Chiabchalard A. Thai plants with high antioxidant levels, free radical scavenging activity, anti-tyrosinase and anti-collagenase activity. BMC Complementary and Alternative Medicine, 2017;17(1):487 — tyrosinase and collagenase inhibition, cosmetic framing. PubMed PMID: 29121910
  2. Uwazie JN, Yakubu MT, Ashafa AOT, Ajiboye TO. Identification and characterization of anti-diabetic principle in Senna alata (Linn.) flower using alloxan-induced diabetic male Wistar rats. Journal of Ethnopharmacology, 2020;261:112997 — flower-derived antidiabetic compound. PubMed PMID: 32534114
  3. Lewis A, Levy A. Anti-inflammatory activities of Cassia alata leaf extract in complete Freund’s adjuvant arthritis in rats. West Indian Medical Journal, 2011;60(6):615-21 — complete Freund’s adjuvant (CFA)-induced arthritis model. PubMed PMID: 22512217
  4. Villaseñor IM, Sanchez AC. Cassiaindoline, a new analgesic and anti-inflammatory alkaloid from Cassia alata. Zeitschrift für Naturforschung C, 2009;64(5-6):335-8 — cassiaindoline, novel alkaloid. PubMed PMID: 19678534
  5. Pasion GCS, Montilla LP, Genuino RF. Efficacy and Safety of Gliricidia sepium, Senna alata, and Tinospora rumphii in the Treatment of Filipino Patients with Scabies: A Systematic Review and Meta-analysis. Acta Medica Philippina, 2025;59(18):16-37 — the two placebo-controlled scabies lotion trials. PubMed PMID: 41502969
  6. PubMed: Acarbose and HbA1c, the drug-class ceiling for the antidiabetic mechanism.

External Resources

Connections

Back to Table of Contents